- the broadest spectrum beta-lactam antibiotic - act bactericidally against virtually all clinically significant pathogens - highly resistant to degradation by bacterial beta-lactamases - effective therapy of severe and live-threatening polymicrobic and mixed aerobic/anaerobic infections
- broad-spectrum tetracycline antibiotic - high activity against atypical pathogens and intracellular parasites - drug of choice for the treatment of infection caused by Mycoplasma, Chlamydia,Chlamydophila, Ureaplasma (incl. PID and respiratory tract infections) - use for the treatment of plague, tularemia, brucellosis, Lime disease, infections caused by Rickettsiae, etc
- excellent selective activity against Gram-negative aerobic bacteria - effective therapy of infection caused by polyresistant pathogens - minimum adverse reactions - can be used in patient with allergy to penicillines and cephalosporines
ABOLmed LLC is one of the Russian leading companies specializing in the development, manufacture and sale of first-class generic pharmaceuticals.
"ABOLmed" LLC
was founded in April 1998 in Moscow, and in a half a year it has
developed the production of cephalosporins family antibiotics for
injection at newly established pharm manufactory in Vidnoe near
Moscow (with 10 million vials annual production capacity).
The
main priorities of "ABOLmed" Ltd Company activity are as
follows: the permanent application of the advanced technologies; the
guarantees of high expansion of the labour productivity and of
excellent product quality; the introduction of new pharmaceuticals in
the Russian market; the investment of research investigations on the
creation of new original drugs; and the raising of the level of
general practitioners skill.
In December 2004,
the "ABOLmed" Ltd Company opened the first order of the new
pharmaceutical factory in Novosibirsk, which had been built for four
years (annual production capacity - 50 million vials). This factory
is in full compliance with GMP standards for pharmaceutical
manufacturing firms.
